FUSION ANTIBODIES PLC |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 3.75 GBX | -1.32% |
|
-1.32% | -11.76% |
| 05-23 | Fusion Antibodies plc Announces New Contract with Existing Client Project to Develop Therapeutic | CI |
| 04-30 | EARNINGS AND TRADING: Software Circle & Beximco report higher revenue | AN |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Sector Other Biotechnology & Medical Research
| Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
|---|---|---|---|---|---|---|
| 4.55M | - | - | - | - | ||
| 54.64B | - | |||||
| 39.92B | ||||||
| 38.82B | ||||||
| 26.86B | ||||||
| 26.22B |
